Proper cut-off value of free to total PSA ratio for detection of prostate cancer in Korean men

Yonsei Medical Journal

Volumn 45, Issue 5, 2004, Pages 873-878

  Im, Young Jae ^a   Kim, Jae Wook ^a   Hong, Sung Joon ^a   Chung, Byung Ha ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Biopsy; Free PSA; Korea; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; KOREA; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; STATISTICAL ANALYSIS; TRANSRECTAL ULTRASONOGRAPHY;

EID: 9144238203     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.5.873     Document Type: Article

References (21)

1. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
2. Dalva I, Akan H, Yildiz O, Telli C, Bingol N. The clinical value of the ratio of free prostate specific antigen to total prostate specific antigen. Int Urol Nephrol 1993; 31:675-80.
3. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, et al. Serum prostate specific antigen as prescreening test for prostate cancer. J Urol 1992;147: 846-51.
4. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992; 147:817-21.
5. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-6.
6. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate specific antigen in a community-based population of healthy man. Establishment of age-specific reference ranges. JAMA 1993;270:860-4.
7. Kalish J, Cooner WH, Graham SD Jr. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1994;43:601-6.
8. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274:1214-20.
9. Zlotta AR, Djavan B, Marberger M, Schulman CC. Prostate specific antigen density of transition zone: a new effective parameter for prostate cancer prediction. J Urol 1997;157:1315-21.
10. Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostate specific antigen and its complex with a-1-antichymotrypsin before diagnosis of prostatic cancer. Lancet 1994;344: 1594-8.
11. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, et al. Use of percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter trial. JAMA 1998;279:1542-7.
12. Ito K, Yamamoto T, Ohi M, Kurokawa K, Suzuki K, Yamanaka H. Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/ml. Urology 2003;61:760-4.
13. Cheon J, Kim CS, Lee ES, Hong SJ, Cho YH, Shin EC, et al. Survey of incidence of urological cancer in South Korea: a 15-year summary. Int J Urol 2002;9:445-54.
14. Lee SE, Kwak C, Park MS, Lee CH, Kang W, Oh SJ. Ethnic differences in the age-related distribution of serum prostate specific antigen values: a study in a healthy Korean male population. Urology 2000;56:1007-10.
15. Ku JH, Ahn JO, Lee CH, Lee NK, Park YH, Byun SS, et al. Distribution of serum prostate specific antigen in healthy Korean men: influence of ethnicity. Urology 2002;60:475-9.
16. Lilja H, Cockett AT, Abrahamsson PA. Prostate specific antigen predominantly forms a complex with a1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum. Cancer 1992;70:230-4.
17. Cookson MS, Floyd MK, Ball TP Jr, Miller EK, Sarosdy MF. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J Urol 1995;154: 1070-3.
18. Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, et al. Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. J Urol 1994;152:1737-40.
19. Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, et al. Significance of serum free prostate specific antigen in the screening of prostate cancer. J Urol 1996;156:1964-8.
20. Pearson JD, Luderer AA, Metter EJ, Partin AW, Chan DW, Fozard JL, et al. Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. Urology 1996;48:4-9.
21. Matsuyama H, Baba Y, Yamakawa G, Yamamoto N, Naito K. Diagnostic value of prostate-specific antigen-related parameters in discriminating prostate cancer. Int J Urol 2000;7:409-14.